Drug companies are still focused on raising prices, but some in the industry realize things need to change
- The US spends far more than other industrialized countries on health care. But Americans, on a per-person basis, don't go to the doctor or hospital more than people in other wealthy nations.
- Health care companies, even not-for-profits like hospitals that don't have typical investors, have prioritized meeting revenue and profitability goals.
- That suggests that pricing practices won't change any time soon.
Health care executives gave no indication to bankers and investors at this year's J.P. Morgan Healthcare Conference that their pricing practices would change any time soon.
Why it matters: That sentiment comes the same week when three of the original authors of an influential 2003 article - which studied why health care is so expensive in the U.S.- published an update. Their conclusion was the same: "It's still the prices, stupid."
- Micron begins construction on $2.7 bn India semiconductor plant in 'epic' beginning
- India, Japan agree to strengthen economic cooperation including achieving progress on high-speed railway project
- India rises to No 1 in ODIs, becomes top ranked team in all formats
- Discover what's new in iOS 17: Your ultimate guide to the latest features
- Hyderabad-based ethnic retailer Sai Silks Kalamandir IPO subscribed 4.4x